2015
DOI: 10.1016/j.lfs.2015.04.015
|View full text |Cite
|
Sign up to set email alerts
|

Leptin: From structural insights to the design of antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 146 publications
0
5
0
Order By: Relevance
“…Leptin is a hormone mainly produced by adipocytes and acts as an efferent satiety signal by virtue of its action on the leptin receptor in the hypothalamus. 17 Zinc has been shown to affect serum leptin levels. Mantzoros et al 18 showed that leptin levels decrease in response to zinc depletion and increase with zinc supplementation.…”
Section: Introductionmentioning
confidence: 99%
“…Leptin is a hormone mainly produced by adipocytes and acts as an efferent satiety signal by virtue of its action on the leptin receptor in the hypothalamus. 17 Zinc has been shown to affect serum leptin levels. Mantzoros et al 18 showed that leptin levels decrease in response to zinc depletion and increase with zinc supplementation.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, module network analysis together with functional analysis showed that (1) genes encoding signal transduction molecules constituted a substantial portion of genes in the compendium and (2) signaling molecules formed a dense network of physical and functional associations. According to the pathway analysis performed with DAVID, genes/proteins from overrepresented signaling pathways are involved in BW regulation, supporting the cellular response to well-known regulators of energy homeostasis, such as insulin [72], leptin [73], neurotrophins (BDNF, NGF) [74], adiponectin [75], PPARs [76], POMC [77], NPY [78], ghrelin [79], etc.…”
Section: Discussionmentioning
confidence: 99%
“…There are no leptin receptor antagonists currently available for clinical use. Lep locus III mutants are currently considered to have potential as antagonists (Zabeau et al, 2015). However, their precise location and nature remain controversial.…”
Section: Lep Analogue Lepr Antagonist and Ghrelinmentioning
confidence: 99%